Serious adverse events among patients with syncope after disposition from emergency department
Serious adverse event | Location of adverse event; no. of patients | ||
---|---|---|---|
Total n = 147 | In hospital n = 86 | Outside hospital n = 61 | |
Death | 21 | 8 | 13 |
Known cause* | 7 | 5 | 2 |
Unknown cause | 14 | 3† | 11 |
Cardiac | 98 | 65 | 33 |
Arrhythmia | |||
Sinus node dysfunction | 18 | 10 | 8 |
New or uncontrolled atrial fibrillation | 7 | 0 | 7 |
High-grade atrioventricular block | 9 | 6 | 3 |
Ventricular arrhythmia | 15 | 11 | 4 |
Supraventricular tachycardia | 2 | 1 | 1 |
Pacemaker insertion | 24 | 21 | 3 |
Other cardiac | |||
Structural heart disease | 11 | 9 | 2 |
Myocardial infarction | 11 | 6 | 5 |
Aortic dissection | 1 | 1 | 0 |
Noncardiac | 35 | 18 | 17 |
Pulmonary embolism | 8 | 6 | 2 |
Gastrointestinal bleeding | 10 | 6 | 4 |
Other‡ | 17 | 6 | 11 |
↵* Patients with a known cause of death had one of the cardiac or noncardiac serious adverse events and hence are not counted toward the total number of patients with serious outcomes.
↵† Multiple causes of death were reported in the medical records, with no clear indication of cause of death.
↵‡ Includes conditions that require acute treatment or that cause a patient to return to hospital if discharged home, such as renal failure requiring dialysis, sepsis, anemia requiring transfusion, acute abdominal conditions (i.e., bowel obstruction, acute appendicitis, ectopic pregnancy, acute presentation of intra-abdominal or pelvic cancer, and cholangitis), lung pathology (i.e., severe pulmonary hypertension, pulmonary fibrosis, and large pleural effusion), acute intracranial pathology (i.e., subarachnoid hemorrhage, posterior circulation stroke, brain tumour, brain metastasis, intracranial hemorrhage, subdural hematoma) and subclavian steal syndrome.